Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Zimmer Biomet Holdings    ZBH

ZIMMER BIOMET HOLDINGS

(ZBH)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsAnalyst Recommendations

Zimmer Biomet Holdings : half-yearly earnings release

07/30/2020 | 09:15am EST

The company will report its earnings for S1 2020 on 08/04/2020. Generally, the company reports earnings in line with the consensus. In recent months, the 8 analysts from Standard & Poor's consensus have revised their EPS estimates downward.


© MarketScreener.com 2020
All news about ZIMMER BIOMET HOLDINGS
12/01ZIMMER BIOMET : Foundation Launches, Supporting Diverse and Underserved Communit..
PR
12/01ZIMMER BIOMET : Completes Acquisition of A&E Medical Corporation
PR
11/18ZIMMER BIOMET : to Present at 2020 Evercore ISI HealthCONx Conference and Piper ..
AQ
11/17ZIMMER BIOMET : to Present at 2020 Evercore ISI HealthCONx Conference and Piper ..
PR
11/09ZIMMER BIOMET : Announces Third Quarter 2020 Financial Results
AQ
11/06ZIMMER BIOMET : Management's Discussion and Analysis of Financial Condition and ..
AQ
11/06ZIMMER : 3Q Earnings Snapshot
AQ
11/06ZIMMER BIOMET HOLDINGS, INC. : Results of Operations and Financial Condition (fo..
AQ
11/06ACELRX PHARMACEUTICALS : Reports Third Quarter 2020 Financial Results
AQ
11/06ZIMMER BIOMET : Announces Preliminary Results from mymobility Clinical Study at ..
AQ
More news
Financials (USD)
Sales 2020 7 058 M - -
Net income 2020 -167 M - -
Net Debt 2020 6 769 M - -
P/E ratio 2020 -179x
Yield 2020 0,66%
Capitalization 30 283 M 30 283 M -
EV / Sales 2020 5,25x
EV / Sales 2021 4,39x
Nbr of Employees 19 900
Free-Float 66,5%
Chart ZIMMER BIOMET HOLDINGS
Duration : Period :
Zimmer Biomet Holdings Technical Analysis Chart | ZBH | US98956P1021 | MarketScreener
Technical analysis trends ZIMMER BIOMET HOLDINGS
Short TermMid-TermLong Term
TrendsBullishBullishNeutral
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 30
Average target price 157,44 $
Last Close Price 146,10 $
Spread / Highest target 19,8%
Spread / Average Target 7,76%
Spread / Lowest Target -27,4%
EPS Revisions
Managers
NameTitle
Bryan C. Hanson President, Chief Executive Officer & Director
Larry C. Glasscock Non-Executive Chairman
Kenneth R. Tripp Senior VP-Global Operations & Logistics
Suketu P. Upadhyay Executive VP, Chief Financial & Accounting Officer
David J. Kunz VP-Global Quality, Clinical & Regulatory Affairs
Sector and Competitors
1st jan.Capitalization (M$)
ZIMMER BIOMET HOLDINGS-2.39%30 283
ABBOTT LABORATORIES24.90%192 284
MEDTRONIC PLC-1.15%150 388
BECTON, DICKINSON AND COMPANY-12.25%69 216
HOYA CORPORATION30.14%49 778
ALIGN TECHNOLOGY, INC.79.22%39 433